Triplex DNA-binding proteins are associated with clinical outcomes revealed by proteomic measurements in patients with colorectal cancer

[1]  H. Tsoi,et al.  Perturbation of U2AF65/NXF1-mediated RNA nuclear export enhances RNA toxicity in polyQ diseases. , 2011, Human molecular genetics.

[2]  Charles Swanton,et al.  Genetic prognostic and predictive markers in colorectal cancer , 2011, Nature Reviews Cancer.

[3]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[4]  Yingye Zheng,et al.  Genomic instability and copy‐number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas , 2011, Molecular oncology.

[5]  D. Cooper,et al.  Non-B DNA-forming Sequences and WRN Deficiency Independently Increase the Frequency of Base Substitution in Human Cells* , 2011, The Journal of Biological Chemistry.

[6]  I. Andricioaei,et al.  Transient Hoogsteen Base Pairs in Canonical Duplex DNA , 2011, Nature.

[7]  Stefan Wiemann,et al.  RNAi-based validation of antibodies for reverse phase protein arrays , 2010, Proteome Science.

[8]  Ravinder Singh,et al.  Genomic mRNA Profiling Reveals Compensatory Mechanisms for the Requirement of the Essential Splicing Factor U2AF , 2010, Molecular and Cellular Biology.

[9]  Ming Yi,et al.  Non-B DB: a database of predicted non-B DNA-forming motifs in mammalian genomes , 2010, Nucleic Acids Res..

[10]  Adrian R. Krainer,et al.  Alternative Splicing of SLC39A14 in Colorectal Cancer is Regulated by the Wnt Pathway* , 2010, Molecular & Cellular Proteomics.

[11]  Heiko A. Mannsperger,et al.  RPPanalyzer: Analysis of reverse-phase protein array data , 2010, Bioinform..

[12]  A. Órfão,et al.  Intratumoural cytogenetic heterogeneity of sporadic colorectal carcinomas suggests several pathways to liver metastasis , 2010, The Journal of pathology.

[13]  G. Sauter,et al.  19q13 amplification is associated with high grade and stage in pancreatic cancer , 2010, Genes, chromosomes & cancer.

[14]  B. Scheithauer,et al.  Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes , 2010, Acta Neuropathologica.

[15]  David J. Chen,et al.  Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response , 2010, Cell cycle.

[16]  Hermann Brenner,et al.  Colorectal cancer and polymorphisms in DNA repair genes WRN, RMI1 and BLM. , 2010, Carcinogenesis.

[17]  W. Kuhne,et al.  Involvement of p54(nrb), a PSF partner protein, in DNA double-strand break repair and radioresistance , 2009, Nucleic acids research.

[18]  R. Wells,et al.  Non‐B DNA conformations as determinants of mutagenesis and human disease , 2009, Molecular carcinogenesis.

[19]  J. Yates,et al.  Molecular architecture of the human pre-mRNA 3' processing complex. , 2009, Molecular cell.

[20]  Qiyi Tang,et al.  Roles of Polypyrimidine Tract Binding Proteins in Major Immediate-Early Gene Expression and Viral Replication of Human Cytomegalovirus , 2009, Journal of Virology.

[21]  P. Jordan,et al.  The beta-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression. , 2008, RNA.

[22]  M. Carmo-Fonseca,et al.  The emerging role of splicing factors in cancer , 2008, EMBO reports.

[23]  Guliang Wang,et al.  DNA triple helices: biological consequences and therapeutic potential. , 2008, Biochimie.

[24]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[25]  J. Meyerhardt,et al.  CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci , 2008, Modern Pathology.

[26]  Hiroyuki Yamamoto,et al.  WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer , 2008, Modern Pathology.

[27]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[28]  L. Chin,et al.  Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types. , 2007, Cancer research.

[29]  P. Hanawalt,et al.  A Triplex-forming Sequence from the Human c-MYC Promoter Interferes with DNA Transcription* , 2007, Journal of Biological Chemistry.

[30]  K. Lilley,et al.  Identification of Internal Ribosome Entry Segment (IRES)-trans-Acting Factors for the Myc Family of IRESs , 2007, Molecular and Cellular Biology.

[31]  Dinshaw J. Patel,et al.  Human telomere, oncogenic promoter and 5′-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics , 2007, Nucleic acids research.

[32]  Jung Hur,et al.  β-Catenin Regulates Multiple Steps of RNA Metabolism as Revealed by the RNA Aptamer in Colon Cancer Cells , 2007 .

[33]  J. Potashkin,et al.  Regulation of Retention of FosB Intron 4 by PTB , 2007, PloS one.

[34]  S. Mirkin.  Expandable DNA repeats and human disease , 2007, Nature.

[35]  S. Hirohashi,et al.  Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing. , 2007, Gastroenterology.

[36]  Stefan Wiemann,et al.  Infrared‐based protein detection arrays for quantitative proteomics , 2007, Proteomics.

[37]  P. Silver,et al.  Genome-wide identification of functionally distinct subsets of cellular mRNAs associated with two nucleocytoplasmic-shuttling mammalian splicing factors , 2006, Genome Biology.

[38]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[39]  N. Hacohen,et al.  RNA interference knockdown of hU2AF35 impairs cell cycle progression and modulates alternative splicing of Cdc25 transcripts. , 2006, Molecular biology of the cell.

[40]  A. Sureau,et al.  The Polypyrimidine Tract Binding Protein (PTB) Represses Splicing of Exon 6B from the β-Tropomyosin Pre-mRNA by Directly Interfering with the Binding of the U2AF65 Subunit , 2006, Molecular and Cellular Biology.

[41]  M. Carmo-Fonseca,et al.  In Vivo Requirement of the Small Subunit of U2AF for Recognition of a Weak 3′ Splice Site , 2006, Molecular and Cellular Biology.

[42]  J. Reich,et al.  Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression , 2006, BMC Genomics.

[43]  R. Stephens,et al.  Long homopurine•homopyrimidine sequences are characteristic of genes expressed in brain and the pseudoautosomal region , 2006, Nucleic acids research.

[44]  R. Wells,et al.  Increased Negative Superhelical Density in Vivo Enhances the Genetic Instability of Triplet Repeat Sequences* , 2005, Journal of Biological Chemistry.

[45]  S. Hirohashi,et al.  β-Catenin Interacts With the FUS Proto-oncogene Product and Regulates Pre-mRNA Splicing , 2005 .

[46]  L. Loeb,et al.  Current advances in unraveling the function of the Werner syndrome protein. , 2005, Mutation research.

[47]  Douglas L. Black,et al.  Polypyrimidine tract binding protein blocks the 5' splice site-dependent assembly of U2AF and the prespliceosomal E complex. , 2005, Molecular cell.

[48]  Robert Castelo,et al.  Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. , 2005, Molecular cell.

[49]  W. Dynan,et al.  Identification of the Polypyrimidine Tract Binding Protein-associated Splicing Factor·p54(nrb) Complex as a Candidate DNA Double-strand Break Rejoining Factor* , 2005, Journal of Biological Chemistry.

[50]  Guliang Wang,et al.  Naturally occurring H-DNA-forming sequences are mutagenic in mammalian cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. V. Van Dyke,et al.  Stm1p, a G4 Quadruplex and Purine Motif Triplex Nucleic Acid-binding Protein, Interacts with Ribosomes and Subtelomeric Y′ DNA in Saccharomyces cerevisiae* , 2004, Journal of Biological Chemistry.

[52]  M. Wollerton,et al.  Polypyrimidine Tract Binding Protein Modulates Efficiency of Polyadenylation , 2004, Molecular and Cellular Biology.

[53]  Y. Shav-Tal,et al.  PSF and p54nrb/NonO – multi‐functional nuclear proteins , 2002, FEBS letters.

[54]  W. Tan,et al.  U2AF Participates in the Binding of TAP (NXF1) to mRNA* , 2002, The Journal of Biological Chemistry.

[55]  J. Darnell,et al.  Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function , 2001, Cell.

[56]  J. Valcárcel,et al.  Nucleocytoplasmic Shuttling of Heterodimeric Splicing Factor U2AF* , 2001, The Journal of Biological Chemistry.

[57]  L. Matrisian,et al.  Stabilized β-catenin immortalizes colonic epithelial cells , 2001 .

[58]  B. Lopez,et al.  Human 100-kDa homologous DNA-pairing protein is the splicing factor PSF and promotes DNA strand invasion. , 2000, Nucleic acids research.

[59]  G. Tiscornia,et al.  Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios. , 2000, Molecular cell.

[60]  B. Robinson,et al.  Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities. , 2000, American journal of respiratory cell and molecular biology.

[61]  M. V. Van Dyke,et al.  The Yeast STM1 Gene Encodes a Purine Motif Triple Helical DNA-binding Protein* , 2000, The Journal of Biological Chemistry.

[62]  Graeme J. Poston,et al.  β‐catenin expression in primary and metastatic colorectal carcinoma , 1999 .

[63]  T. Straub,et al.  The RNA-splicing Factor PSF/p54 Controls DNA-Topoisomerase I Activity by a Direct Interaction* , 1998, The Journal of Biological Chemistry.

[64]  M. V. Van Dyke,et al.  Characterization of purine-motif triplex DNA-binding proteins in HeLa extracts. , 1998, Biochemistry.

[65]  Y. Nakamura,et al.  Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. , 1998, Cancer research.

[66]  Michael R. Green,et al.  Targeting of U2AF65 to Sites of Active Splicing in the Nucleus , 1997, The Journal of cell biology.

[67]  J. Valcárcel,et al.  Sequential recognition of the pre-mRNA branch point by U2AF65 and a novel spliceosome-associated 28-kDa protein. , 1995, RNA.

[68]  W. Gilbert,et al.  A Yeast Gene Product, G4p2, with a Specific Affinity for Quadruplex Nucleic Acids (*) , 1995, The Journal of Biological Chemistry.

[69]  Xiang-Dong Fu,et al.  Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma. , 1993, The Journal of clinical investigation.

[70]  C. Croce,et al.  Mapping chromosomal breakpoints of Burkitt's t(8;14) translocations far upstream of c-myc. , 1992, Cancer research.

[71]  M. Green,et al.  Biochemical characterization of U2 snRNP auxiliary factor: an essential pre‐mRNA splicing factor with a novel intranuclear distribution. , 1991, The EMBO journal.

[72]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[73]  Michael R. Green,et al.  A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly , 1988, Cell.

[74]  A. Bacolla,et al.  Non-B DNA structure-induced genetic instability and evolution , 2009, Cellular and Molecular Life Sciences.

[75]  M. Muckenthaler,et al.  Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes , 2008, Acta Neuropathologica.

[76]  Tesshi Yamada,et al.  Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. , 2005, Gastroenterology.

[77]  L. Matrisian,et al.  Stabilized beta-catenin immortalizes colonic epithelial cells. , 2001, Cancer research.

[78]  B Getty,et al.  beta-catenin expression in primary and metastatic colorectal carcinoma. , 1999, International journal of cancer.

[79]  S. Mirkin,et al.  Triplex DNA structures. , 1995, Annual review of biochemistry.